357 related articles for article (PubMed ID: 26155779)
1. Adherence to WCRF/AICR lifestyle recommendations for cancer prevention and the risk of Barrett's esophagus onset and evolution to esophageal adenocarcinoma: results from a pilot study in a high-risk population.
Realdon S; Antonello A; Arcidiacono D; Dassie E; Cavallin F; Fassan M; Nardi MT; Alberti A; Rugge M; Battaglia G
Eur J Nutr; 2016 Jun; 55(4):1563-71. PubMed ID: 26155779
[TBL] [Abstract][Full Text] [Related]
2. Risk factors in the development of esophageal adenocarcinoma.
Pohl H; Wrobel K; Bojarski C; Voderholzer W; Sonnenberg A; Rösch T; Baumgart DC
Am J Gastroenterol; 2013 Feb; 108(2):200-7. PubMed ID: 23247577
[TBL] [Abstract][Full Text] [Related]
3. Resident Esophageal Microbiota Dysbiosis Correlates with Cancer Risk in Barrett's Esophagus Patients and Is Linked to Low Adherence to WCRF/AICR Lifestyle Recommendations.
Zaramella A; Arcidiacono D; Nucci D; Fabris F; Benna C; Pucciarelli S; Fassan M; Fantin A; De Re V; Cannizzaro R; Realdon S
Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447211
[TBL] [Abstract][Full Text] [Related]
4. Does physical activity protect against the development of gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma? A review of the literature with a meta-analysis.
Lam S; Hart AR
Dis Esophagus; 2017 Nov; 30(11):1-10. PubMed ID: 28881908
[TBL] [Abstract][Full Text] [Related]
5. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
[TBL] [Abstract][Full Text] [Related]
6. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
[TBL] [Abstract][Full Text] [Related]
7. Lifestyle, WCRF/AICR Recommendations, and Esophageal Adenocarcinoma Risk: A Systematic Review of the Literature.
Nucci D; Marino A; Realdon S; Nardi M; Fatigoni C; Gianfredi V
Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684526
[TBL] [Abstract][Full Text] [Related]
8. Role of obesity in Barrett's esophagus and cancer.
Murray L; Romero Y
Surg Oncol Clin N Am; 2009 Jul; 18(3):439-52. PubMed ID: 19500735
[TBL] [Abstract][Full Text] [Related]
9. The diagnosis and management of Barrett's esophagus.
DeMeester SR; DeMeester TR
Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
[TBL] [Abstract][Full Text] [Related]
10. Barrett's esophagus and risk of esophageal adenocarcinoma.
Cossentino MJ; Wong RK
Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
[TBL] [Abstract][Full Text] [Related]
11. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
[TBL] [Abstract][Full Text] [Related]
12. Dietary antioxidants and risk of Barrett's esophagus and adenocarcinoma of the esophagus in an Australian population.
Ibiebele TI; Hughes MC; Nagle CM; Bain CJ; Whiteman DC; Webb PM;
Int J Cancer; 2013 Jul; 133(1):214-24. PubMed ID: 23292980
[TBL] [Abstract][Full Text] [Related]
13. Influence of body mass index on the prevalence and progression of dysplasia in Barrett's esophagus: a retrospective analysis (.).
Thota PN; Arora Z; Benjamin T; Pagadala M; Lopez R; Sanaka MR
Scand J Gastroenterol; 2016 Nov; 51(11):1288-93. PubMed ID: 27460942
[TBL] [Abstract][Full Text] [Related]
14. Barrett's surveillance identifies patients with early esophageal adenocarcinoma.
Wong T; Tian J; Nagar AB
Am J Med; 2010 May; 123(5):462-7. PubMed ID: 20399324
[TBL] [Abstract][Full Text] [Related]
15. Rat Reflux Model of Esophageal Cancer and Its Implication in Human Disease.
Greene CL; Worrell SG; DeMeester TR
Ann Surg; 2015 Dec; 262(6):910-24. PubMed ID: 25822684
[TBL] [Abstract][Full Text] [Related]
16. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
[TBL] [Abstract][Full Text] [Related]
17. Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's oesophagus.
Kubo A; Corley DA; Jensen CD; Kaur R
Nutr Res Rev; 2010 Dec; 23(2):230-46. PubMed ID: 20624335
[TBL] [Abstract][Full Text] [Related]
18. Dietary antioxidant and mineral intake in humans is associated with reduced risk of esophageal adenocarcinoma but not reflux esophagitis or Barrett's esophagus.
Murphy SJ; Anderson LA; Ferguson HR; Johnston BT; Watson PR; McGuigan J; Comber H; Reynolds JV; Murray LJ; Cantwell MM
J Nutr; 2010 Oct; 140(10):1757-63. PubMed ID: 20702746
[TBL] [Abstract][Full Text] [Related]
19. Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia.
Anaparthy R; Gaddam S; Kanakadandi V; Alsop BR; Gupta N; Higbee AD; Wani SB; Singh M; Rastogi A; Bansal A; Cash BD; Young PE; Lieberman DA; Falk GW; Vargo JJ; Thota P; Sampliner RE; Sharma P
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1430-6. PubMed ID: 23707463
[TBL] [Abstract][Full Text] [Related]
20. Response to TNF-α Is Increasing Along with the Progression in Barrett's Esophagus.
Chemnitzer O; Götzel K; Maurer L; Dietrich A; Eichfeld U; Lyros O; Jansen-Winkeln B; Hoffmeister A; Gockel I; Thieme R
Dig Dis Sci; 2017 Dec; 62(12):3391-3401. PubMed ID: 29086334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
